• Prion-Based Assembly Tunes Mutagenesis and Adaptation

  2026-09-14

  The Cell study shows that prion-like protein self-assembly can act as a reversible, heritable switch for genome diversification rather than merely altering a single cellular trait. In yeast, this state-dependent control reshapes DNA repair and recombination, accelerates adaptation under strong selection, and contributes to the emergence of fluconazole resistance in Candida albicans.

• Heparin sodium: Workflows for Thrombosis Research

  2026-09-13

  Heparin sodium (SKU A5066) supports orthogonal anti-factor Xa and aPTT workflows, while its polyanionic biology creates a useful, carefully controlled probe for heparan sulfate proteoglycan-dependent nanovesicle uptake. This guide connects anticoagulation assays with the reference study’s Sertoli-cell model without overstating what has been experimentally validated.

• Butylhydroxyanisole (BHA): Assay Design Guide

  2026-09-12

  Butylhydroxyanisole (BHA) is more than a generic antioxidant control: its chemistry, solvent behavior, and assay timing can determine how oxidative-stress data should be interpreted. This guide connects BHA redox workflows with orthogonal validation principles from peptide pharmacology to improve ROS, apoptosis, and inflammation experiments.

• Tetracycline Hydrochloride: Mechanism & Workflow

  2026-09-11

  Tetracycline Hydrochloride is a bacteriostatic antibiotic that inhibits bacterial protein synthesis through interaction with the 30S ribosomal subunit and 16S rRNA. Product data support research use against Staphylococcus aureus and Propionibacterium acnes, while solvent handling, assay context, and the limits of translating in vitro potency require careful control.

• Difloxacin HCl: From Gyrase to Translational Strategy

  2026-09-11

  A mechanistic and strategic guide to using Difloxacin HCl across antimicrobial susceptibility testing and multidrug resistance research, while defining the evidence boundaries for cross-domain links to mitotic checkpoint biology.

• Minocycline HCl in Scalable EV Inflammation Models

  2026-09-10

  Use Minocycline HCl as a mechanistic comparator, inflammation-control reagent, and troubleshooting tool alongside scalable iMSC extracellular vesicle workflows. This article translates a 2025 bioreactor study into practical assay designs while separating validated EV findings from concentration and handling recommendations.

• MG-132: Reliable Proteasome Inhibition Workflows

  2026-09-10

  This scenario-driven guide explains how MG-132, SKU A2585, can improve the interpretation and reproducibility of viability, apoptosis, ROS, and cell-cycle experiments. It covers mechanism, cell-line differences, solution handling, data interpretation, and practical vendor-selection criteria.

• Difloxacin HCl: Workflows for Susceptibility Testing

  2026-09-09

  Difloxacin HCl supports two distinct research workflows: bacterial antimicrobial susceptibility testing and exploratory multidrug resistance reversal studies. This guide combines practical preparation, assay design, troubleshooting, and a carefully bounded connection to Plk1-regulated mitotic checkpoint research.

• MG-132 Workflows for Apoptosis and ROS Studies

  2026-09-09

  Build more informative proteasome-inhibition experiments with MG-132 (Z-LLL-al), from concentration-response design to orthogonal apoptosis, ROS, and cell-cycle readouts. This workflow also shows how to use the compound as a carefully bounded perturbation when exploring host-proteostasis effects in antiviral assay systems.

• Minocycline HCl in EV Bioactivity Assays

  2026-09-08

  Discover how Minocycline HCl can function as a mechanistic perturbation tool in extracellular-vesicle bioactivity assays. This article connects minocycline hydrochloride pharmacology with scalable EPSC-iMSC-EV manufacturing while emphasizing causal controls, formulation, and translational limitations.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus

  2026-09-08

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus is an ARCA capped mRNA synthesis kit designed for translation-ready RNA. This article connects cap and poly(A) design with assay selection, nanovaccine development, and practical quality-control decisions.

• Epoxomicin for Proteasome Pathway Research

  2026-09-07

  Epoxomicin provides a selective, irreversible way to test whether protein loss, inflammatory signaling, or disease-relevant phenotypes depend on 20S proteasome activity. This guide translates that chemistry into practical protein degradation assays and a mechanistic workflow inspired by viral RIPK3 research.

• Deferoxamine mesylate: Assay Reliability Guide

  2026-09-07

  A scenario-based guide to using Deferoxamine mesylate (SKU B6068) for iron-dependent oxidative stress, hypoxia signaling, viability, proliferation, and cytotoxicity workflows. It connects assay design, dose selection, interpretation, and supplier evaluation with product data and current ferroptosis research.

• GTP Solution for p21 mRNA Synthesis

  2026-09-05

  A practical guide to using a nuclease-free GTP Solution in IVT workflows that support p21 mRNA–LNP research. It connects nucleotide handling, RNA quality control, and localized bladder cancer delivery while separating evidence from optimization recommendations.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-04

  Breen and colleagues developed a drug-sensitized Saccharomyces cerevisiae platform that markedly improves detection of TOR inhibitors by combining TOR-pathway mutations with deletion of drug-efflux genes. The study validates the system with established inhibitors and shows that canagliflozin produced no evidence of TOR inhibition in this yeast growth model, an informative negative result for pathway-selective screening.

8641 records 6/577 page Previous Next First page 上5页 678910 下5页 Last page